Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SLS
SLS logo

SLS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

SLS News

Investors Focus on Middle East Developments and Job Data

6d agostocktwits

Merck's Acquisition Sparks Interest in Blood Cancer Drug Market

6d agostocktwits

SLS Shares Surge Following Merck's Tern Acquisition, Fueling Buyout Speculation in Blood Cancer Sector: Retail Investors Eye Major Pharma Contender

6d agostocktwits

SLS vs. TERN: Which Pharmaceutical Stock Offers Greater Potential as Merck Plans $6B Investment in Cancer Ahead of Keytruda Patent Expiration?

Mar 25 2026stocktwits

Sellas Life Sciences Shows Significant Clinical Progress

Mar 20 2026stocktwits

SELLAS Life Sciences Reports 2025 Financials and Clinical Updates

Mar 20 2026NASDAQ.COM

Sellas Life Sciences Narrows FY25 Net Loss Amid Promising Trials

Mar 20 2026stocktwits

SELLAS Life Sciences FY 2025 Earnings Beat Expectations

Mar 19 2026seekingalpha

SLS Events

03/25 08:50
DeFi Development Corp Borrow Rate Increases to 30.28%
Latest data shows the largest indicative borrow rate increases among liquid option names include: DeFi Development Corp (DFDV) 30.28% +4.39, SoundHound AI (SOUN) 10.74% +3.17, Sellas Life Sciences (SLS) 39.23% +2.10, Direxion S&P Biotech Bear 3X (LABD) 14.50% +1.35, Defiance Daily Target 2X Long HIMS ETF (HIMZ) 17.88% +1.19, Direxion Daily South Korea Bull 3X Shares (KORU) 11.67% +1.15, FAS (FAS) 3.13% +0.98, US Antimony (UAMY) 6.94% +0.84, Infosys (INFY) 7.92% +0.74, and ProShares Ultra QQQ (QLD) 1.98% +0.73.

SLS Monitor News

Sellas Life Sciences Group Inc stock drops amid market strength

Jan 06 2026

SELLAS Life Sciences shares surge on positive REGAL trial updates

Jan 05 2026

Sellas Life Sciences Group Inc reaches 52-week high amid REGAL trial progress

Dec 29 2025

SLS Earnings Analysis

No Data

No Data

People Also Watch